Multi-drug resistant tuberculosis: where should we be with optimal treatment?

Affiliations

¹ Department of Infectious Diseases, Galliera Hospital, Genoa, Italy.
² Servizio di Epidemiologia Clinica delle Malattie Respiratorie, Istituti Clinici Scientifici Maugeri IRCCS, Tradate, Italy.
³ Public Health Consulting Group, Lugano, Switzerland.
⁴ Faculdade de Medicina, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, Brazil.
⁵ CHIP, Centre of Excellence for Health, Immunity and Infections, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.
⁶ Department for Respiratory Medicine and Infectious Diseases, Copenhagen University Hospital - Bispebjerg, Copenhagen, Denmark.

Editorial

Emanuele Pontali et al. Expert Rev Anti Infect Ther. 2025 Jul.

. 2025 Jul;23(7):425-428.

doi: 10.1080/14787210.2025.2506777. Epub 2025 May 19.

¹ Department of Infectious Diseases, Galliera Hospital, Genoa, Italy.
² Servizio di Epidemiologia Clinica delle Malattie Respiratorie, Istituti Clinici Scientifici Maugeri IRCCS, Tradate, Italy.
³ Public Health Consulting Group, Lugano, Switzerland.
⁴ Faculdade de Medicina, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, Brazil.
⁵ CHIP, Centre of Excellence for Health, Immunity and Infections, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.
⁶ Department for Respiratory Medicine and Infectious Diseases, Copenhagen University Hospital - Bispebjerg, Copenhagen, Denmark.

No abstract available

Keywords: MDR-TB; TB; XDR-TB; new regimens; tuberculosis.

Publication types